Amino acid replacement: E?K.
Nucleotide substitution: G94A.
G657203A
G94A
E32K | SkpA-PA; E32K | SkpA-PB; E32K | SkpA-PC; E32K | SkpA-PD; E32K | SkpA-PE; E32K | SkpA-PF; E32K | SkpA-PG; E32K | SkpA-PH; E32K | SkpA-PI
E?K
The mutation is reported to be a change from G to A at base 94. Assiming that refers to base 94 of of the CDS, it was mapped to codon E32.
NMJ bouton | larval stage | maternal effect (with SkpA1)
NMJ bouton | larval stage | maternal effect (with SkpAG0389)
Homozygous larvae derived from homozygous females show a significant increase in the number of boutons and number of synaptic branches at the neuromuscular junction compared to wild type, while the size of the boutons is significantly reduced. Heterozygous larvae derived from homozygous females also show a significant increase in the number of boutons at the neuromuscular junction compared to wild type, although this overgrowth phenotype is less severe than that seen for homozygous larvae derived from homozygous females.
Mutant larvae show a decrease in axonal degeneration after crush injury compared to wild type.
SkpAGD65 has abnormal neuroanatomy | maternal effect | larval stage phenotype, suppressible | partially by Scer\GAL4elav.PU/JraJbz.UAS
SkpAGD65 has abnormal neuroanatomy | maternal effect | larval stage phenotype, suppressible | partially by Scer\GAL4elav.PU/kayFbz.UAS
SkpAGD65 has abnormal neuroanatomy | maternal effect | larval stage phenotype, suppressible | partially by Scer\GAL4elav.PU/bskK53R.UAS
Scer\GAL4elav.PU, SkpAGD65, fafUAS.cUa has lethal | dominant phenotype, suppressible | partially by wnd1/wnd2
SkpAGD65 has abnormal neurophysiology | larval stage phenotype, suppressible | partially by wnd1/wnd2
SkpAGD65 is an enhancer of abnormal neuroanatomy | larval stage phenotype of hiwND51
SkpAGD65 is a suppressor of abnormal neuroanatomy | larval stage phenotype of α-SpecKK101541, Scer\GAL4elav.PU
Scer\GAL4elav.PU, SkpAGD65, fafUAS.cUa has lethal | dominant phenotype
SkpAGD65 has NMJ bouton | maternal effect | larval stage phenotype, suppressible | partially by wnd1/wnd2
SkpAGD65 has embryonic/larval neuromuscular junction | maternal effect | larval stage phenotype, suppressible | partially by wnd1/wnd2
SkpAGD65 has NMJ bouton | maternal effect | larval stage phenotype, suppressible | partially by Scer\GAL4elav.PU/JraJbz.UAS
SkpAGD65 has embryonic/larval neuromuscular junction | maternal effect | larval stage phenotype, suppressible | partially by Scer\GAL4elav.PU/JraJbz.UAS
SkpAGD65 has NMJ bouton | maternal effect | larval stage phenotype, suppressible | partially by Scer\GAL4elav.PU/kayFbz.UAS
SkpAGD65 has embryonic/larval neuromuscular junction | maternal effect | larval stage phenotype, suppressible | partially by Scer\GAL4elav.PU/kayFbz.UAS
SkpAGD65 has NMJ bouton | maternal effect | larval stage phenotype, suppressible | partially by Scer\GAL4elav.PU/bskK53R.UAS
SkpAGD65 has embryonic/larval neuromuscular junction | maternal effect | larval stage phenotype, suppressible | partially by Scer\GAL4elav.PU/bskK53R.UAS
SkpAGD65 is an enhancer of NMJ bouton | larval stage phenotype of hiwND51
SkpAGD65 is an enhancer of embryonic/larval neuromuscular junction | larval stage phenotype of hiwND51
SkpAGD65 is a suppressor of embryonic/larval neuromuscular junction | larval stage phenotype of α-SpecKK101541, Scer\GAL4elav.PU
The synaptic overgrowth phenotype (increase in bouton number) seen at the neuromuscular junction in hiwND51 mutants is dramatically enhanced in hiwND51 SkpAGD65 double mutants.
hiwND51 SkpAGD65 double mutant larvae show a decrease in excitatory junctional potential amplitude and in quantal content compared to wild type.
The synaptic overgrowth phenotype (increase in bouton number) seen at the neuromuscular junction in larvae derived from homozygous SkpAGD65 females is significantly (but not completely) suppressed by wnd1/wnd2.
The synaptic overgrowth phenotype (increase in bouton number) seen at the neuromuscular junction in larvae derived from homozygous SkpAGD65 females is partially suppressed by expression of one of either JraJbz.Scer\UAS, kayFbz.Scer\UAS or bskK53R.Scer\UAS under the control of Scer\GAL4elav.PU.
The synaptic retraction phenotype seen at the neuromuscular junction in larvae expressing α-SpecKK101541 under the control of Scer\GAL4elav.PU is suppressed by SkpAGD65.
The reduced axonal degeneration seen in SkpAGD65 larvae compared to controls after crush injury is suppressed by expression of NmnatJF03337 under the control of Scer\GAL4tey-5053A.
SkpAGD65/SkpA1 is rescued by Scer\GAL4elav.PU/SkpAUAS.Tag:FLAG,Tag:HA
SkpAGD65/SkpA1 is not rescued by SkpAUAS.Tag:FLAG,Tag:HA/Scer\GAL4G7
The neuromuscular junction overgrowth phenotype (increase in number of boutons) seen in larvae derived from SkpAGD65/SkpA1 females is completely rescued by expression of SkpAScer\UAS.T:Zzzz\FLAG,T:Ivir\HA1 under the control of Scer\GAL4elav.PU, while expression under the control of Scer\GAL4G7 does not rescue the phenotype.